We are live on ! Find out more
EAM

Eukles Asset Management Portfolio holdings

AUM $224M
1-Year Est. Return 18.27%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+18.27%
3 Year Est. Return
+69.7%
5 Year Est. Return
+91.47%
10 Year Est. Return
AUM
$180M
AUM Growth
+$25.8M
Cap. Flow
+$15.8M
Cap. Flow %
8.73%
Top 10 Hldgs %
28.8%
Holding
249
New
35
Increased
109
Reduced
5
Closed
5

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.14M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.03M
3
MSFT icon
Microsoft
MSFT
+$614K
4
ACN icon
Accenture
ACN
+$446K
5
MA icon
Mastercard
MA
+$435K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 15.69%
3 Financials 12.02%
4 Industrials 10.74%
5 Consumer Discretionary 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$7.09M 3.93%
26,183
+2,415
+10% +$614K
IWF icon
2
iShares Russell 1000 Growth ETF
IWF
$122B
$6.77M 3.75%
99,684
+1,316
+1% +$84.8K
AAPL icon
3
Apple
AAPL
$4.89T
$6.65M 3.68%
48,523
+16,515
+52% +$2.14M
RMD icon
4
ResMed
RMD
$28.3B
$5.07M 2.81%
20,575
+1,354
+7% +$285K
ACN icon
5
Accenture
ACN
$89.9B
$4.86M 2.69%
16,485
+1,559
+10% +$446K
LH icon
6
Labcorp
LH
$24.3B
$4.46M 2.47%
18,830
+949
+5% +$216K
BALL icon
7
Ball Corp
BALL
$17B
$4.38M 2.43%
54,051
+3,311
+7% +$287K
MA icon
8
Mastercard
MA
$477B
$4.34M 2.41%
11,901
+1,169
+11% +$435K
VCSH icon
9
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$4.22M 2.34%
50,990
+140
+0.3% +$11.6K
EFA icon
10
iShares MSCI EAFE ETF
EFA
$76.4B
$4.13M 2.29%
52,338
+12,989
+33% +$1.03M
IWP icon
11
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$4.03M 2.23%
35,577
+48
+0.1% +$5.13K
PYPL icon
12
PayPal
PYPL
$49.5B
$3.93M 2.18%
13,488
+603
+5% +$159K
SPSB icon
13
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$3.85M 2.13%
123,021
+375
+0.3% +$11.7K
CBOE icon
14
Cboe Global Markets
CBOE
$29.8B
$3.53M 1.96%
29,644
+1,842
+7% +$202K
SWKS icon
15
Skyworks Solutions
SWKS
$9.06B
$3.48M 1.93%
18,173
+1,065
+6% +$189K
CHE icon
16
Chemed
CHE
$6.78B
$3.28M 1.82%
6,910
+242
+4% +$116K
CAT icon
17
Caterpillar
CAT
$409B
$3.23M 1.79%
14,862
+1,254
+9% +$290K
SHW icon
18
Sherwin-Williams
SHW
$78.3B
$3.16M 1.75%
11,587
+319
+3% +$87.4K
ROK icon
19
Rockwell Automation
ROK
$51.4B
$3.11M 1.73%
10,887
+174
+2% +$46.9K
ZTS icon
20
Zoetis
ZTS
$31.6B
$3.06M 1.7%
16,441
+1,276
+8% +$222K
EMN icon
21
Eastman Chemical
EMN
$7.8B
$3.05M 1.69%
26,156
+1,219
+5% +$146K
FDS icon
22
Factset
FDS
$9.05B
$2.99M 1.66%
8,901
+171
+2% +$56K
CBRE icon
23
CBRE Group
CBRE
$40.8B
$2.8M 1.55%
32,612
+2,094
+7% +$179K
TJX icon
24
TJX Companies
TJX
$170B
$2.63M 1.46%
38,961
+2,224
+6% +$152K
ORCL icon
25
Oracle
ORCL
$331B
$2.6M 1.44%
33,362
+1,858
+6% +$145K

Similar funds

Eukles Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Eukles Asset Management held 249 positions worth $180M, up 17% from $155M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eukles Asset Management deployed $15.8M of net new capital in Q2 2021, opening 35 new positions and adding to 109 existing holdings. Its largest new stake was Walker & Dunlop: 3,468 shares worth $362K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Morgan Stanley, an estimated $345K trimmed.

  • Eukles Asset Management's largest Q2 2021 buy was Walker & Dunlop: 3,468 shares worth $362K.
  • Eukles Asset Management added most to Apple in Q2 2021, an estimated $2.14M increase.
  • Eukles Asset Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $345K.
  • Eukles Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $3.61M.
  • Eukles Asset Management's ten largest holdings make up 29% of its $180M portfolio in Q2 2021.
  • Eukles Asset Management opened 35 new positions and closed 5 in Q2 2021.
  • Eukles Asset Management's portfolio value rose 17% quarter-over-quarter to $180M.

Based on Eukles Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.